Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Experience of 3-Year Treatment With Dupilumab: Significant Decrease in Circulating Neutrophils and Eosinophils in Japanese Patients With Atopic Dermatitis.
Nakajima H, Kamata M, Okada Y, Suzuki S, Ito M, Watanabe A, Egawa S, Chijiwa C, Hiura A, Tomura Y, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Tada Y. Nakajima H, et al. Among authors: fukuyasu a. Exp Dermatol. 2024 Nov;33(11):e70010. doi: 10.1111/exd.70010. Exp Dermatol. 2024. PMID: 39487715
Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.
Suzuki S, Kamata M, Uchida H, Shimizu T, Okada Y, Ito M, Watanabe A, Mizukawa I, Egawa S, Chijiwa C, Hiura A, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Tada Y. Suzuki S, et al. Among authors: fukuyasu a. J Dermatol. 2024 Oct 20. doi: 10.1111/1346-8138.17512. Online ahead of print. J Dermatol. 2024. PMID: 39428667
Possibility of maintaining remission with topical therapy alone after withdrawal of dupilumab in Japanese patients with atopic dermatitis and their characteristics in the real world.
Watanabe A, Kamata M, Okada Y, Suzuki S, Ito M, Uchida H, Chijiwa C, Egawa S, Hiura A, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Tada Y. Watanabe A, et al. Among authors: fukuyasu a. Exp Dermatol. 2024 Sep;33(9):e15175. doi: 10.1111/exd.15175. Exp Dermatol. 2024. PMID: 39277874
Erythema multiforme after initiating spesolimab in a patient with generalized pustular psoriasis with IL36RN mutation.
Nakajima H, Kamata M, Okada Y, Ito M, Watanabe A, Azuma S, Uchida H, Egawa S, Chijiwa C, Hiura A, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Sugiura K, Tada Y. Nakajima H, et al. Among authors: fukuyasu a. Eur J Dermatol. 2024 Jun 1;34(3):324-325. doi: 10.1684/ejd.2024.4711. Eur J Dermatol. 2024. PMID: 39015980 No abstract available.
Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not inteleukin-17 inhibitors.
Takeshima R, Kamata M, Suzuki S, Ito M, Watanabe A, Uchida H, Chijiwa C, Okada Y, Azuma S, Nagata M, Egawa S, Hiura A, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Tada Y. Takeshima R, et al. Among authors: fukuyasu a. J Dermatol. 2024 Sep;51(9):1216-1224. doi: 10.1111/1346-8138.17277. Epub 2024 May 28. J Dermatol. 2024. PMID: 38804254
308-nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single-center real-world experience of treatment for palmoplantar pustulosis.
Niimura Y, Kamata M, Ishikawa T, Nagata M, Ito M, Watanabe A, Egawa S, Uchida H, Hiura A, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Tada Y. Niimura Y, et al. Among authors: fukuyasu a. J Dermatol. 2024 Jul;51(7):977-984. doi: 10.1111/1346-8138.17191. Epub 2024 Mar 14. J Dermatol. 2024. PMID: 38483008
Expression of interleukin-36 receptor antagonist in a patient with generalized pustular psoriasis harboring the p.Pro82Leu variant in the IL36RN gene.
Mizukawa I, Kamata M, Shimizu T, Ito M, Watanabe A, Uchida H, Egawa S, Nagata M, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Sugiura K, Tada Y. Mizukawa I, et al. Among authors: fukuyasu a. J Dermatol. 2023 Dec;50(12):1608-1613. doi: 10.1111/1346-8138.16914. Epub 2023 Jul 31. J Dermatol. 2023. PMID: 37525499
Safety and effectiveness of fosravuconazole for the treatment of onychomycosis in haemodialysis patients: A single-centre retrospective study.
Uchida H, Kamata M, Ishikawa T, Ito M, Watanabe A, Egawa S, Hiura A, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Tada Y. Uchida H, et al. Among authors: fukuyasu a. J Eur Acad Dermatol Venereol. 2023 Dec;37(12):e1455-e1457. doi: 10.1111/jdv.19363. Epub 2023 Aug 1. J Eur Acad Dermatol Venereol. 2023. PMID: 37467371 No abstract available.
42 results